Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-07

Clinical Trial Update: Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing a responsive intervention to prevent mother-to-child transmission of HIV-1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 | Phase 3 | Status: COMPLETED